Sustained Analgesia Achieved Through Esterase-Activated Morphine Prodrugs Complexed with PAMAM Dendrimer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmaceutical Research

• Publication date

  2012-09-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11095-012-0869-3PMID 23054086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The facile synthesis of multifunctional PAMAM dendrimer conjugates through copper-free click chemistry.

  2012cited by this paper
• Copper-free click conjugation of methotrexate to a PAMAM dendrimer platform.

  2011cited by this paper
• Plasma-mediated release of morphine from synthesized prodrugs.

  2010cited by this paper
• Mental health and posttraumatic stress symptoms 2 years after severe multiple trauma: self-reported disability and psychosocial functioning.

  2010cited by this paper
• Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.

  2008cited by this paper
• Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles.

  2007cited by this paper
• The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

  2007cited by this paper
• Fluorescence visualization of newly synthesized proteins in mammalian cells.

  2006cited by this paper
• Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro.

  2006cited by this paper
• Comprehensive characterization of surface-functionalized poly(amidoamine) dendrimers with acetamide, hydroxyl, and carboxyl groups

  2006cited by this paper
• Electrophoretic mobility and molecular distribution studies of poly(amidoamine) dendrimers of defined charges

  2006cited by this paper
• HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

  2006cited by this paper
• Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations.

  2006cited by this paper
• HPLC analysis of PAMAM dendrimer based multifunctional devices.

  2005cited by this paper
• Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

  2005cited by this paper
• Analysis of poly(amidoamine)‐succinamic acid dendrimers by slab‐gel electrophoresis and capillary zone electrophoresis

  2005cited by this paper
• Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.

  2005cited by this paper
• Generational, skeletal and substitutional diversities in generation one poly(amidoamine) dendrimers

  2005cited by this paper
• Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group.

  2005cited by this paper
• Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.

  2005cited by this paper
• J.Chromatogr., B: Anal. Technol. Biomed. Life Sci.

  2004cited by this paper
• Dendritic molecular capsules for hydrophobic compounds.

  2003cited by this paper
• Acetylation of Poly(amidoamine) Dendrimers

  2003cited by this paper
• Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.

  2003cited by this paper
• Dendritic polymer macromolecular carriers for drug delivery.

  2002cited by this paper
• Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor

  2002cited by this paper
• The persistent problem with pain.

  2001cited by this paper
• The persistent problem with pain

  2001cited by this paper
• Central Neuroplasticity and Pathological Pain

  2001cited by this paper
• Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

  2001cited by this paper
• Improvement of buccal delivery of morphine using the prodrug approach

  1997cited by this paper
• Bioactivation of morphine-3-propionate, a prodrug of morphine, in tissues from different species

  1997cited by this paper
• Synthesis, opioid receptor affinity, and enzymatic hydrolysis of sterically hindered morphine 3-esters.

  1996cited by this paper
• Encapsulation of Guest Molecules into a Dendritic Box

  1994cited by this paper
• Utilization of prodrugs to enhance the transdermal absorption of morphine

  1991cited by this paper
• Lipidic peptides. III: Lipidic amino acid and oligomer conjugates of morphine.

  1991cited by this paper
• Hydrolysis of copolyesters containing aromatic and aliphatic ester blocks by lipase

  1981cited by this paper
• A method for measurement of analgesic activity on inflamed tissue.

  1957cited by this paper
• A method for measurement of analgesic activity on inflamed tissue.

  1957cited by this paper
• The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform

  year unknowncited by this paper

• Nanomedicine in the Use of Opioids: Enhancing Analgesia, Mitigating Harm

  2026cites this paper
• Engineering Stimuli-Responsive Dendrimers for Drug Delivery: A 15-Year Review of Formulation Strategies and Routes of Administration

  2026cites this paper
• Prodrug approaches for the development of a long-acting drug delivery systems.

  2023cites this paper
• Micro- and Nanocarriers for pain alleviation.

  2022cites this paper
• Recent advances in nanoplatforms for the treatment of neuropathic pain

  2022cites this paper
• Improved antiallodynic, antihyperalgesic and anti-inflammatory response achieved through potential prodrug of curcumin, curcumin diethyl diglutarate in a mouse model of neuropathic pain.

  2021cites this paper
• New method of identifying morphine in urine samples using nanoparticle-dendrimer-enzyme hybrid system

  2021cites this paper
• Recent Advances in Peripheral Opioid Receptor Therapeutics

  2021cites this paper
• Peripherally acting opioid analgesics and peripherally-induced analgesia

  2020cites this paper
• Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis

  2019cites this paper
• Administration Routes for Nano Drugs and Characterization of Nano Drug Loading

  2019cites this paper
• Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo.

  2019cites this paper
• Nanotechnology application for pain therapy

  2018cites this paper
• Development of Poly(lactide-co-glicolide) Nanoparticles Incorporating Morphine Hydrochloride to Prolong its Circulation in Blood.

  2017cites this paper
• Pharmacokinetics and Paw Withdrawal Pressure in Female Guinea Pigs (Cavia porcellus) Treated with Sustained-Release Buprenorphine and Buprenorphine Hydrochloride.

  2016cites this paper
• Prodrugs targeting the central nervous system (cns)

  2015cites this paper
• Polyester Dendrimers: Smart Carriers for Drug Delivery

  2014cites this paper
• Endogenous opiates and behavior: 2013.

  2014cites this paper
• The use of lipid-based nanocarriers for targeted pain therapies

  2013cites this paper
• The Discovery of a Facile Access to the Synthesis of NSAID Dendritic Prodrugs

  2013cites this paper
• Physiological Feedback Control 2011-2012 Annual Report

  2013cites this paper
• Dendritic Polymer for Drug Delivery Applications

  year unknowncites this paper